Follow
Tanja A. Arnouk
Title
Cited by
Cited by
Year
Alternatives to dimethylsulfoxide for serum-free cryopreservation of human mesenchymal stem cells
TA Grein, D Freimark, C Weber, K Hudel, C Wallrapp, P Czermak
The International journal of artificial organs 33 (6), 370-380, 2010
632010
Purification of a recombinant baculovirus of Autographa californica M nucleopolyhedrovirus by ion exchange membrane chromatography
TA Grein, R Michalsky, M Vega López, P Czermak
Journal of virological methods 183 (2), 117-124, 2012
432012
Aeration and shear stress are critical process parameters for the production of oncolytic measles virus
TA Grein, D Loewe, H Dieken, T Weidner, D Salzig, P Czermak
Frontiers in bioengineering and biotechnology 7, 78, 2019
362019
Multiphase mixing characteristics in a microcarrier-based stirred tank bioreactor suitable for human mesenchymal stem cell expansion
TA Grein, J Leber, M Blumenstock, F Petry, T Weidner, D Salzig, ...
Process Biochemistry 51 (9), 1109-1119, 2016
352016
High titer oncolytic measles virus production process by integration of dielectric spectroscopy as online monitoring system
TA Grein, D Loewe, H Dieken, D Salzig, T Weidner, P Czermak
Biotechnology and Bioengineering 115 (5), 1186-1194, 2018
272018
Forced degradation studies to identify critical process parameters for the purification of infectious measles virus
D Loewe, J Häussler, TA Grein, H Dieken, T Weidner, D Salzig, ...
Viruses 11 (8), 725, 2019
242019
Screening different host cell lines for the dynamic production of measles virus
TA Grein, F Schwebel, M Kress, D Loewe, H Dieken, D Salzig, T Weidner, ...
Biotechnology Progress 33 (4), 989-997, 2017
212017
Virus separation using membranes
TA Grein, R Michalsky, P Czermak
Animal Cell Biotechnology: Methods and Protocols, 459-491, 2014
212014
Concepts for the production of viruses and viral vectors in cell cultures
TA Grein, T Weidner, P Czermak
New insights into cell culture technology 10, 62590, 2017
192017
Tangential flow filtration for the concentration of oncolytic measles virus: The influence of filter properties and the cell culture medium
D Loewe, TA Grein, H Dieken, T Weidner, D Salzig, P Czermak
Membranes 9 (12), 160, 2019
162019
Opportunities to debottleneck the downstream processing of the oncolytic measles virus
D Loewe, H Dieken, TA Grein, T Weidner, D Salzig, P Czermak
Critical reviews in biotechnology 40 (2), 247-264, 2020
152020
Membrane supported virus separation from biological solutions
TA Grein, Z Kovacs, M Ebrahimi, R Michalsky, P Czermak
Chemie Ingenieur Technik 85 (8), 1183-1192, 2013
142013
Purification of oncolytic measles virus by cation-exchange chromatography using resin-based stationary phases
D Eckhardt, H Dieken, D Loewe, TA Grein, D Salzig, P Czermak
Separation Science and Technology 57 (6), 886-896, 2022
122022
A combined ultrafiltration/diafiltration process for the purification of oncolytic measles virus
D Loewe, H Dieken, TA Grein, D Salzig, P Czermak
Membranes 12 (2), 105, 2022
82022
Turbidimetry and dielectric spectroscopy as process analytical technologies for mammalian and insect cell cultures
L Käßer, J Zitzmann, T Grein, T Weidner, D Salzig, P Czermak
Animal Cell Biotechnology: Methods and Protocols, 335-364, 2020
62020
Aeration and shear stress are critical process parameters for the production of oncolytic measles virus. Front Bioeng Biotechnol 7: 78
TA Grein, D Loewe, H Dieken, T Weidner, D Salzig, P Czermak
52019
Process for producing a purified rhabdovirus from cell culture
D Mueller, AP Garcia, TA Grein, F Kaess, NG Judy, K Pesta, S Schneider, ...
US Patent App. 17/371,159, 2022
22022
Reprint of “Multiphase mixing characteristics in a microcarrier-based stirred tank bioreactor suitable for human mesenchymal stem cell expansion”
TA Grein, J Leber, M Blumenstock, F Petry, T Weidner, D Salzig, ...
Process biochemistry 59, 266-275, 2017
12017
STEM BASED CELL THERAPEUTIC IMPLANTS: PRODUCTION AND STORAGE
D Freimark, C Sehl, TA Grein, C Weber, K Hudel, B Glasmacher, ...
INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS 33 (7), 426-426, 2010
12010
Process Analytical Technologies (PAT) and Quality by Design (QbD) for Bioprocessing of Virus-Based Therapeutics
M Schad, S Gautam, TA Grein, F Käß
Bioprocess and Analytics Development for Virus-based Advanced Therapeutics …, 2023
2023
The system can't perform the operation now. Try again later.
Articles 1–20